Skip to content

Melatonin on Post Operative Pain After CS

The Effect of Preoperative Oral Melatonin on Postoperative Pain Control After Cesarean Section: A Dose Comparison Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07380568
Acronym
CS
Enrollment
60
Registered
2026-02-02
Start date
2025-10-10
Completion date
2026-04-01
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain Management, Pain After Surgery, Cesarean Section Pain

Keywords

melatonin and pain after C.S

Brief summary

The goal of this clinical trial is to learn if melatonin will decrease pain after C.S. The main questions it aims to answer are: Does melatonin lower the number of times participants need to use a rescue analgesia? What medical problems do participants have when taking melatonin? Researchers will compare different doses of melatonin to see the ideal dose to decrease pain after C.S. Participants will: Take melatonin 30 min before C.S and will be observed for 24 hours for pain and consumption of other analgesia

Interventions

Group I: (5 mg melatonin): Participants will receive 5 mg of oral melatonin 1 hours before the cesarean section.

Group II: (10 mg melatonin): Participants will receive 10 mg of oral melatonin 1 hours before the cesarean section.

DRUGPlacebo

Group III: (Placebo): Participants will receive an identical placebo tablet 1 hours before the cesarean section.

Sponsors

Benha University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* \- Women aged 18-40 years. * Scheduled for elective cesarean section. * Ability to provide informed consent.

Exclusion criteria

* Known hypersensitivity to melatonin or opioids * Chronic use of analgesics, sedatives, or antidepressants. * History of sleep disorders or psychiatric illness. * Complicated pregnancies (e.g., preeclampsia, gestational diabetes). * Body mass index (BMI) \> 35 kg/m². * Emergency cesarean sections. * Severe systemic diseases (e.g., liver or kidney dysfunction).

Design outcomes

Primary

MeasureTime frameDescription
Postoperative pain intensity measured using the VAS (Visual Analogue Scale)2, 6, 12, and 24 hours post-surgery.it typically consists of a 100 mm straight line with descriptive anchors at each end representing the extremes of the sensation (for example, "no pain" at one end and "the most severe pain imaginable" at the other). Respondents indicate their experience by marking a point on the line, and the distance from the lower anchor is measured and recorded as a continuous variable

Secondary

MeasureTime frameDescription
first rescue analgesiathe first 24 hours post operativeTime to first request for analgesia postoperatively
Total opioid consumptionthe first 24 hours post operativeamount of opioid requested by the patient
Incidence of adverse effectsfirst 24 hours post operativesuch as nausea, vomiting, headache, dizziness, sedation
Time to first ambulation post-surgeryfirst 24 hours post operativefirst movement by the patient

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026